-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) PT Raised to $110 at Piper Sandler
-
-
-
-
-
-
-
Monte Rosa Therapeutics (GLUE) PT Raised to $37 at Piper Sandler
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised at Piper Sandler Following Positive BroADen Data
-
-
-
-
-
-
-
Arvinas Inc. (ARVN) PT Raised to $16 at Piper Sandler
-
-
-
-
-
-
-
Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight
-
-
-
-
-
-
-
Piper Sandler: 'What Biotech Names to Own in Market Volatility'
-
-
-
-
-
-
-
Century Therapeutics (IPSC) PT Slashed to $4 at Piper Sandler Following Termination of the Bristol-Myers Alliance
-
381 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

